Delray Beach, FL, June 06, 2025 (GLOBE NEWSWIRE) — The global sleep apnea devices market valued at US$6.0 billion in 2023, stood at US$6.5 billion in 2024 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2029, culminating in a forecasted valuation of US$9.3 billion by the end of the period. The sleep apnea devices market is experiencing significant growth opportunities driven by the adoption of telemedicine, mHealth, and artificial intelligence for treatment and diagnosis, along with the expansion of leading players into emerging markets like India, Australia, UAE, and Saudi Arabia. Increased investments and funding are fostering innovations in CPAP devices and diagnostics, improving patient compliance and accessibility to advanced solutions. However, insufficient awareness of sleep apnea and poor adherence to CPAP devices pose challenges to market expansion. The rising popularity of cost-effective home sleep apnea tests and next-generation sleep-sensing technologies offers further growth potential. In 2023, the PAP devices segment led the therapeutic devices market, while home care settings dominated the end-user segment. The Asia Pacific region observed the highest growth rate due to a large patient pool with comorbidities and an increasing number of sleep clinics. Key market players include ResMed, Koninklijke Philips N.V., and Fisher & Paykel Healthcare Limited, noted for their extensive product portfolios and wide geographic presence.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719
Browse in-depth TOC on “Sleep Apnea Devices Market”
483 – Tables
50 – Figures
366 – Pages
RESMED (US): Market Leader in Sleep Apnea Devices
ResMed (US) led the sleep apnea devices market in 2023, renowned for its innovative and advanced therapeutic and diagnostic devices. The company’s focus on healthcare technology expertise enables it to produce accurate and efficient sleep apnea devices, securing a significant market share. By expanding its product offerings, including PAP devices and facial interfaces, ResMed has maintained its market leadership.
KONINKLIJKE PHILIPS N.V. (Netherlands): Major Player in Sleep Apnea Devices
In 2023, Koninklijke Philips N.V. (Netherlands) held the second-largest share of the sleep apnea devices market. Known for its innovative and user-friendly health monitoring devices, Philips is expanding its global presence through strategic partnerships and acquisitions. These efforts increase accessibility and awareness of sleep apnea solutions in emerging and developing markets.
FISHER & PAYKEL HEALTHCARE LIMITED (New Zealand): Innovator in Patient Comfort
Fisher & Paykel Healthcare Limited (New Zealand) secured the third-largest share of the sleep apnea devices market in 2023. The company’s Hospitals and Homecare segments drive sales of sleep apnea devices. Focused on product development, Fisher & Paykel emphasizes advanced humidification and mask technologies to enhance patient comfort and therapeutic effectiveness, thereby expanding its market presence.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=719
Product Segmentation: Therapeutic Devices Lead the Sleep Apnea Devices Market
The sleep apnea devices market is segmented by product into therapeutic devices and diagnostic devices. In 2023, the therapeutic devices segment accounted for the largest share, driven by the launch of advanced and non-invasive therapeutic sleep apnea devices. Therapeutic devices include positive airway pressure (PAP) devices, facial interfaces (masks), accessories, oral appliances, and other therapeutic devices, all contributing to the segment’s growth.
End User Segmentation: Home Care Settings Dominate
The sleep apnea devices market is categorized by end users into sleep laboratories, clinics, hospitals, and home care settings/individuals. In 2023, home care settings/individuals held the largest market share. Devices used in home care settings, such as PAP devices, nasal masks, oral appliances, ambulatory PSG, oxygen concentrators, and pulse oximeters, are preferred for their ease of use and patient preference for home sleep testing over testing in sleep laboratories, clinics, and hospitals.
Age Group Segmentation: 40-60 Years Lead
The sleep apnea devices market is divided by age group into below 40 years, 40–60 years, and above 60 years. In 2023, the 40-60 years segment accounted for the largest share. High awareness and diagnosis rates, along with the rise in comorbidities such as hypertension and diabetes in this age group, contribute to its dominance. This age group is more adaptable to sleep apnea therapeutic technology for health management compared to other age groups.
Gender Segmentation: Male Patients Lead
The sleep apnea devices market is segmented by gender into male and female patients. In 2023, male patients dominated the market, driven by the higher prevalence of hypertension, cardiovascular disease, stroke, and daytime sleepiness among men compared to women. This higher prevalence results in increased diagnosis and treatment rates in the male population.
Regional Insights: Asia Pacific Offers Significant Growth Opportunities
The global sleep apnea devices market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is expected to offer significant growth opportunities for sleep apnea device manufacturers over the next 5-10 years. This growth is driven by increasing cases of comorbidities such as diabetes and cardiovascular diseases, as well as growing awareness of sleep apnea, which leads to higher diagnosis rates.
For more information, inquire now! Inquire Now
Related Reports:
Medical Equipment Maintenance Market
Respiratory Care Devices Market
Respiratory Diagnostics Market
Ultrasound Market
Diagnostic Imaging Market
Get access to the latest updates on Sleep Apnea Devices Companies and Sleep Apnea Devices Market Share
CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit Our Website: www.marketsandmarkets.com
